Recent studies from several countries, including the United States, have indicated that the incidence rate of intrahepatic cholangiocarcinoma is increasing while that of extrahepatic cholangiocarcinoma is decreasing. We examined whether such opposing trends could be confirmed in Danish data. We computed the nationwide Danish incidence rates of intra-and extrahepatic cholangiocarcinomas from January 1 The median age at diagnosis decreased during the study period, and the proportion of localized cancers increased. The decrease in cholangiocarcinoma incidence rates cannot be explained by time trends in known risk factors (e.g., inflammatory bowel disease, diabetes, smoking, or thorotrast), but our findings are consistent with a common etiology for intra-and extrahepatic cholangiocarcinomas.
angiocarcinomas as the number of new diagnoses in a particular year divided by the number of Danish citizens at the beginning of that year (publicly available through http://www.statistikbanken.dk ) and standardized to the US population in 2000; 95% confi dence intervals (CIs) were based on the assumption of Poisson-distributed counts. We used a Poisson regression model to estimate the annual change in age-and sex-specifi c cholangiocarcinoma incidence.
We identifi ed 1335 intrahepatic cholangiocarcinomas and 1269 extrahepatic cholangiocarcinomas with standardized incidence rates of 0.90 (95% CI = 0.86 to 0.95) and 0.86 (95% CI = 0.81 to 0.90) per 100 000 people per year, respectively. The incidence rates increased with age ( Table 1 ) .
Incidence rates and time trends were similar for the two types of cholangiocarcinomas. The incidence rates for intra-and extrahepatic cholangiocarcinomas in 1978 were 1.27 (95% CI = 0.96 to 1.58) and 1.05 (95% CI = 0.77 to 1.34) per 100 000 people, respectively. From the mid-1980s, the incidence rates started to decrease ( Fig. 1 ) , and in 2002, the incidence rates for intra-and extrahepatic cholangiocarcinomas were 0.46 (95% CI = 0.29 to 0.62) and 0.74 (95% CI = 0.53 to 0.95) per 100 000 people, respectively. The incidence rate decreased by 3.7% (95% CI = 3.0% to 4.4%) and 2.7% (95% CI = 1.9% to 3.4%) per year for intra-and extrahepatic cholangiocarcinomas, respectively. The incidence decrease was observed in both sexes and in all three arbitrarily defi ned age-groups (i.e., <60, 60 -79, and ≥ 80 years; Table 1 ) and persisted after exclusion of autopsy diagnoses (data not shown). Individuals aged 80
Recent studies have suggested that the incidence rates of intrahepatic cholangiocarcinoma have increased in most areas of the world, including the United States, and those of extrahepatic cholangiocarcinoma have decreased ( 1 -3 ) . These opposing trends are puzzling, and, to our knowledge, no plausible explanation has been proposed. We examined the incidence rates of in traand extrahepatic cholangiocarcinomas in Denmark to evaluate whether, over a 25-year period, the opposing trends could be confi rmed with data from the high-quality nationwide Danish Cancer Registry.
Denmark has a population of 5.3 million with free tax-supported health care. Every diagnosis of cancer must be reported to the Danish Cancer Registry, and each report includes the patient's unique personal identifi er, the month and year of diagnosis, and, from January 1, 1978, through December 31, 2002, topology and histology codes according to the International Classifi cation of Diseases for Oncology, 1st Edition (ICD-O-1) ( 4 ). The cancer stage (localized, regional spread, or metastatic spread) and macroscopic basis for the diagnosis, including information on whether the diagnosis was made at autopsy, are also reported.
We identifi ed all cases of intra-and extrahepatic cholangiocarcinomas by following the defi nitions used by Welzel et al. If any patient was registered with more than one cholangiocarcinoma, only their earliest diagnosis was included in the analysis.
We computed the annual Danish incidence rates of intra-and extrahepatic chol-
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years or older had the largest decrease in incidence ( Table 1 ) In the period from 1978 through 1982, 22% (95% CI = 16% to 28%) of intrahepatic cholangiocarcinomas were localized compared with 31% (95% CI = 23% to 40%) in the period from 1998 through 2002. A similar improvement was observed for extrahepatic cholangiocarcinomas, from 20% (95% CI = 15% to 27%) localized in the period from 1978 through 1982 to 32% (95% CI = 24% to 42%) in that from 1998 through 2002.
The primary strength of this study is the quality of the Danish Cancer Registry. The registry is notifi ed of all cancers diagnosed by general practitioners, practicing specialists, or hospital doctors or in institutes of pathology or forensic medicine, and registration is virtually complete ( 5 ). Accuracy of a cancer diagnosis is ensured by crosschecking the information from the clinician's notifi cation with the information from the pathologist's notifi cation, and contacting them if the information is not consistent ( 5 ) . A limitation of our study was that cholangiocarcinoma topography may have been incorrectly reported by clinicians, but it is unlikely that misclassifi cation between intra-and extrahepatic cholangiocarcinomas had a major systematic impact on incidence rates or on time trends in incidence rates.
We designed our study to allow direct comparisons with the US incidence rates presented by Welzel et al. ( 3 ) . The extrahepatic cholangiocarcinoma rates for the United States and Denmark were nearly identical throughout the period from 1978 through 2002. The intrahepatic 
CONTEXT AND CAVEATS

Prior knowledge
Data from several countries, including the United States, indicate that the incidence rate of intrahepatic cholangiocarcinoma is increasing while that of extrahepatic cholangiocarcinoma is decreasing.
Study design
Population-based cancer registry study.
Contribution
Incidence rates for both cancers in Denmark decreased from 1978 through 2002.
Implications
Intra-and extrahepatic cholangiocarcinomas may share the same biology.
Limitations
Only partial information on the prevalence of risk factors for cholangiocarcinoma was available. Misclassification is possible because cholangiocarcinoma topography may have been incorrectly reported.
cholangiocarcinoma rates, however, were three times higher in Denmark than in the United States until the mid-1980s, when the US rate started to increase and the Danish rate started to decrease. From approximately 1990, rates in the United States and Denmark were nearly identical. Thus, we found no signs of opposite incidence trends for intraand extrahepatic cholangiocarcinomas in Denmark, unlike those in the United States and several other regions of the world ( 2 ) . Changes in diagnostic methods are unlikely to explain our fi ndings. New diagnostic tools improve sensitivity and/or specifi city, and higher sensitivity cannot explain a lower cholangiocarcinoma incidence. We included only diagnoses that were based on histologic examination; although not all histology codes in our cholangiocarcinoma defi nition were specifi c to cholangiocarcinoma, there was no sign that the less specifi c codes were more frequent in the beginning of the study period. Also, the decrease in autopsies could not explain the decreasing cholangiocarcinoma incidence.
A limitation of our study was that we had only partial information on the prevalence of cholangiocarcinoma risk factors. The most important risk factors for cholangiocarcinoma in a Western population include primary sclerosing cholangitis and other biliary diseases, infl ammatory bowel disease, infection with hepatitis C virus, diabetes, smoking, thorotrast (i.e., a mixture containing radioactive thorium dioxide particles that was used as a contrast medium for x-ray diagnostics between 1930 and 1950), alcoholism, and liver cirrhosis ( 6 -9 ) . The prevalence of smoking has decreased in Denmark, although primarily among men ( 10 ) , so other factors must be responsible for the larger cholangio carcinoma incidence decrease among women. In addition, smoking prevalence has decreased in countries with increasing cholangiocarcinoma incidence ( 11 ) . The prevalence of thorotrast exposure has also decreased, but only 1000 Danes were exposed, with none of them exposed after 1947 ( 12 ) . The prevalence of infl ammatory bowel disease and diabetes has increased ( 13 , 14 ) , and there is no indication that the prevalence of the remaining risk factors has decreased. Thus, none of the known cholangiocarcinoma risk factors can explain our fi ndings.
In conclusion, intra-and extrahepatic cholangiocarcinomas may share the same biology. It remains unclear why the incidence rates have decreased in Denmark and are now similar to those in the United States.
